This article is more than 5 years old. Information may no longer be current.

InVivo hires new CEO, interim CFO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

InVivo Therapeutics Holdings Corp announced the appointment of Mark D. Perrin as chief executive officer and Steven McAllister as interim chief financial officer.

Along with the role of new chief executive officer, Perrin will also become a member of the board of directors at InVivo. Most recently, Perrin served as president of Dennan Consulting and before that he served as president and chief executive officer of ConjuChem Biotechnologies from 2005 to 2010. He was executive vice president and chief commercial officer for Orphan Medical until it was acquired by Jazz Pharmaceuticals from 2002 to 2005. Prior to that, he was executive vice president, commercial operations for COR Therapeutics, as well as vice president for Burroughs Wellcome and Lederle Laboratories, with responsibility for U.S. commercial operations at each company.

“Mark is an excellent fit for InVivo. His extensive commercial background will be invaluable to portfolio decision for our novel hydrogel technology and our new emphasis on partnering as a primary way to finance new programs,” John McCarthy, chairman of InVivo, stated in a company press release.

McAllister served as vice president, finance and administration for Biomet Spine and Bone Healing Technologies from 2007 to 2013. According to a company press release, he served as director of finance, worldwide operations, for DePuy Inc. from 1999 to 2007 and worked in several capacities at Howmedica from 1984 to 1999.